Clinical manifestations and course in children with homozygous and compound heterozygous nondeletional alpha-thalassemia

BACKGROUNDHemoglobin Constant Spring (HbCS) is the most common nondeletional alpha-globin variant in Thailand, followed by hemoglobin Paksé (HbPS).Small pediatric studies have suggested that most patients with homozygous hemoglobin Constant Spring disease (HbCS/CS) have mild anemia with a low mean corpuscular volume (MCV).However, data on homozygous HbPS or compound heterozygous HbCS and HbPS (HbCS/PS) remain limited.AIM To evaluate the clinical manifestations, course, and red cell parameters of children with homozygous and compound heterozygous HbCS and HbPS.METHODS A single-center retrospective observational cohort study was conducted in children younger than 15 years with homozygous and compound heterozygous HbCS and HbPS diagnosed at Siriraj Hospital, Bangkok, Thailand, between January 1998 and December 2022.Clinical manifestations and red cell parameters were summarized descriptively, without formal comparisons.RESULTS Forty-six patients were identified, including 38 with HbCS/CS and 8 with HbCS/PS.The median age at presentation was 21 days.At initial evaluation, the median hemoglobin (Hb), hematocrit, and MCV were 8.6 g/dL [interquartile range (IQR), 6.9-10.1],27.6% (IQR: 21.8%-31.6%),and 78.6 fL (IQR: 66.2-103.4),respectively.Presenting features ranged from incidental detection to hemolytic anemia.Twelve patients (26.1%; 95%CI: 15.6%-40.3%)presented prenatally, including 4 fetuses (8.7%; 95%CI: 3.4%-20.3%)with 4 / 35 hydrops and severe anemia requiring intrauterine transfusion.Twenty-one patients received at least 1 blood transfusion, with 1 requiring regular transfusion for 18 months.Nineteen patients experienced hemolytic events after diagnosis.At steady state, the median Hb level was 10.4 g/dL.Median follow-up was 4.9 years. CONCLUSIONHbCS/CS and HbCS/PS showed variable presentations, including fetal anemia.Small sample sizes necessitated a strictly descriptive approach without genotype-phenotype comparisons.Close monitoring of at-risk pregnancies is warranted.

Authors

Institutions

Publication Details

Journal
World Journal of Clinical Pediatrics
Published
2026-11-18
DOI
https://doi.org/10.5409/wjcp.127430
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical manifestations and course in children with homozygous and compound heterozygous nondeletional alpha-thalassemia

Waraporn Glomglao, Krittin Rattananont, Kamon Phuakpet, Mongkol Chanvanichtrakool et al.
1 links
World Journal of Clinical Pediatrics
Hemoglobinopathies and Related Disorders
article

Clinical manifestations and course in children with homozygous and compound heterozygous nondeletional alpha-thalassemia

Waraporn Glomglao, Krittin Rattananont, Kamon Phuakpet, Mongkol Chanvanichtrakool, Kleebsabai Sanpakit, Nalat Sompagdee, Nassawee Vathana, Jassada Buaboonnam
article en

Abstract

BACKGROUNDHemoglobin Constant Spring (HbCS) is the most common nondeletional alpha-globin variant in Thailand, followed by hemoglobin Paksé (HbPS).Small pediatric studies have suggested that most patients with homozygous hemoglobin Constant Spring disease (HbCS/CS) have mild anemia with a low mean corpuscular volume (MCV).However, data on homozygous HbPS or compound heterozygous HbCS and HbPS (HbCS/PS) remain limited.AIM To evaluate the clinical manifestations, course, and red cell parameters of children with homozygous and compound heterozygous HbCS and HbPS.METHODS A single-center retrospective observational cohort study was conducted in children younger than 15 years with homozygous and compound heterozygous HbCS and HbPS diagnosed at Siriraj Hospital, Bangkok, Thailand, between January 1998 and December 2022.Clinical manifestations and red cell parameters were summarized descriptively, without formal comparisons.RESULTS Forty-six patients were identified, including 38 with HbCS/CS and 8 with HbCS/PS.The median age at presentation was 21 days.At initial evaluation, the median hemoglobin (Hb), hematocrit, and MCV were 8.6 g/dL [interquartile range (IQR), 6.9-10.1],27.6% (IQR: 21.8%-31.6%),and 78.6 fL (IQR: 66.2-103.4),respectively.Presenting features ranged from incidental detection to hemolytic anemia.Twelve patients (26.1%; 95%CI: 15.6%-40.3%)presented prenatally, including 4 fetuses (8.7%; 95%CI: 3.4%-20.3%)with 4 / 35 hydrops and severe anemia requiring intrauterine transfusion.Twenty-one patients received at least 1 blood transfusion, with 1 requiring regular transfusion for 18 months.Nineteen patients experienced hemolytic events after diagnosis.At steady state, the median Hb level was 10.4 g/dL.Median follow-up was 4.9 years. CONCLUSIONHbCS/CS and HbCS/PS showed variable presentations, including fetal anemia.Small sample sizes necessitated a strictly descriptive approach without genotype-phenotype comparisons.Close monitoring of at-risk pregnancies is warranted.

World Journal of Clinical Pediatrics
Siriraj Hospital (TH), Mahidol University (TH)
Faculty of Medicine Siriraj Hospital, Mahidol University
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon